Pyxis Oncology (PYXS) Ending Cash Balance (2020 - 2026)
Pyxis Oncology (PYXS) recorded Ending Cash Balance of $20.33 million in Q2 2026, up 66.5% from $12.21 million a year earlier.
Powered by 
Analysis
Pyxis Oncology (PYXS) Ending Cash Balance (2020 - 2026) Analysis & Trends
For FY2025, Pyxis Oncology reported Ending Cash Balance of $16.89 million, down 19.3% from FY2024.
- Annual Ending Cash Balance has a five-year compound annual growth rate of 15.6% (FY2020 to FY2025).
- Across earlier years, Ending Cash Balance came in at $20.95 million in FY2024 (+88.1%), $11.14 million in FY2023 (-93.8%), $180.77 million in FY2022 (-34.6%) and $276.32 million in FY2021.
- The Q2 2026 figure is the highest quarterly Ending Cash Balance since Q4 2024.
- On a year-over-year basis, Ending Cash Balance rose in two of the last seven quarters, with an average decline of 1.4%.
- Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 88.1% in Q4 2024, against a decline of 93.8% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Pyxis Oncology | 136.12 Mn | -60.32 Mn | - | 5.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.33 Mn |
| Jun 30, 2026 | 20.33 Mn |
| Mar 31, 2026 | 7.24 Mn |
| Dec 31, 2025 | 16.89 Mn |
| Sep 30, 2025 | 10.39 Mn |
| Jun 30, 2025 | 12.21 Mn |
| Mar 31, 2025 | 14.23 Mn |
| Dec 31, 2024 | 20.95 Mn |
| Sep 30, 2024 | 13.53 Mn |
| Jun 30, 2024 | 26.55 Mn |
| Mar 31, 2024 | 29.44 Mn |
| Dec 31, 2023 | 11.14 Mn |
| Sep 30, 2023 | 16.19 Mn |
| Jun 30, 2023 | 27.37 Mn |
| Mar 31, 2023 | 54.53 Mn |
| Dec 31, 2022 | 180.77 Mn |
| Sep 30, 2022 | 200.01 Mn |
| Jun 30, 2022 | 224.83 Mn |
| Mar 31, 2022 | 248.67 Mn |
| Dec 31, 2021 | 276.32 Mn |
API Access
Pyxis Oncology Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PYXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "PYXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PYXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();